Market Situation
Steady increases until 2020
- Shorter overall investment periods
- More capital-raise events
- 67% increase in number of deals per year over the last decade
- 73% aggregate deal-value increase
- Increase in pro-seller terms followed these curves
Private-Target M&A Deal Counts and Volume
COVID-19: Deal terms are changing, and some impacts may last
Material Adverse Effects
- Pandemic carveouts are the norm with occasional carveouts for law compliance
Interim Operating Covenants / Reps and Warranties Disclosures
- Qualifiers for “ordinary course of business” and employment status
Purchase Price Adjustments and PPP Loans
- New guidance regarding repayment and escrow requirements for PPP loans
Earnouts
- Increase in use of EBITDA or earnings measurement versus revenue
Protect Your Negotiations & Deals
Taxes
- Opportunities to negotiate refunds (CARES Act)
- Tax audit timing is longer, resulting in delayed escrow releases
Earnout Cases
- Online clothing company: Earnout provisions require open stores and pre-COVID operations
- Pharmaceuticals: Clinical trials delayed beyond milestone deadline
Holdbacks
- Buyer’s ability to pay depends on available cash and solvency
- Solvency impacts how claims are negotiated and resolved
Stock Deals
- Stock escrows fluctuate quickly in value, further pressurizing decisions
- Similar sense of urgency where buyer stock (in escrow or holdback) is declining in value